Global Biopsy Equipment Market (2021 to 2026)

DUBLIN, March 19, 2021 / PRNewswire / – Added Report “Biopsy Equipment Market: Global Industry Trend, Share, Size, Growth, Opportunity and Forecast 2021-2026”’s offering.

The global biopsy devices market has reached a value of $ 2.12 billion US in 2020. Biopsy machines refer to various equipment used for surgical removal of tissues from an organ. Surgeons, radiologists, cardiologists and other medical doctors use them to detect the presence or extent of diseases that are cancer or inflammation in nature. Equipment such as aspiration needles, twigs and local wires are some of the commonly used biopsy devices. These devices are used in biopsies with MRI parts, based on needle, heart and empty support, including the liver, lungs, kidneys and breasts. They seek wide applications across a number of healthcare centers, such as medical clinics, diagnostic centers and hospitals.

The rising times of harmful medical conditions, especially breast cancer, is one of the key factors driving the growth of the market. In addition, there is an increase in consumer awareness of access to diagnostic and screening procedures for breast diseases, raising demand for integrated technologies such as stereotactic-guided biopsies. There is also a growing preference for minimally invasive biopsy (MI) procedures among patients worldwide. For example, the MI breast biopsy (MIBT) method eliminates the need for surgery to diagnose cancer while preserving healthy tissue from radiation-induced damage. In addition, there are a number of technological advances, including the development of vacuum-assisted guns and smart biopsy systems that help differentiate healthy cells from fake ones, also for market growth. Other factors, including the rapidly growing geriatric population, rising healthcare spending and extensive research and development (R&D) activities are expected to drive the market in the years to come. Looking ahead, the publisher expects the biopsy devices market to reach a value of $ 2.87 billion US by 2026, exhibiting a CAGR of 5.12% in 2021-2026.

Competitive Landscape:

The competitive landscape of the industry was also examined by some of the key players Argon Medical Devices Inc., B. Braun Melsungen, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Cook Group Incorporated, Danaher Corporation, Hologic Inc., Medtronic Inc., etc.

Key questions answered in this report:

  • How has the global biopsy devices market performed so far and how will it perform in the coming years?
  • What are the main regional markets?
  • What has been the impact of COVID-19 on the global biopsy devices market?
  • What is market disruption based on the type of approach?
  • What is a product-based market break?
  • What is application-based market disruption?
  • What is a market break based on the management method?
  • What is end-user based market disruption?
  • What are the different levels in the business value chain?
  • What are the key drivers and challenges in the industry?
  • What is the structure of the global biopsy devices market and who are the key players?
  • What is the level of competition in the industry?

Key topics covered:

1 Introduction

2 Scope and Approach
2.1 Aims of the study
2.2 Stakeholders
2.3 Data sources
2.3.1 Key Sources
2.3.2 Secondary Sources
2.4 Market measurement
2.4.1 Bottom up approach
2.4.2 A top-down approach
2.5 Preview Procedure

3 Executive Minutes

4 Introduction
4.1 Outlook
4.2 Key industry trends

5 Global Biopsy Equipment Market
5.1 Market outlook
5.2 Market Performance
5.3 Impact of COVID 19
5.4 Market outlook

6 Market breakdown by type of procedure
6.1 Surgical biopsy
6.1.1 Market trends
6.1.2 Market outlook
6.2 Needle biopsy
6.2.1 Market trends
6.2.2 Market forecast

7 Market breakdown by output
7.1 Biopsy control systems
7.1.1 Market trends
7.1.2 Market outlook
7.2 Needle-based Biopsy Guns
7.2.1 Market trends
7.2.2 Market forecast
7.3 Biopsy needles
7.3.1 Market trends
7.3.2 Market forecast
7.4 Wood biopsy
7.4.1 Market trends
7.4.2 Market forecast
7.5 Other
7.5.1 Market trends
7.5.2 Market outlook

8 Market break with application
8.1 Breast biopsy
8.1.1 Market trends
8.1.2 Market outlook
8.2 Lung biopsy
8.2.1 Market trends
8.2.2 Market forecast
8.3 Colorectal biopsy
8.3.1 Market trends
8.3.2 Market forecast
8.4 Prostate Biopsy
8.4.1 Market trends
8.4.2 Market forecast
8.5 Other
8.5.1 Market trends
8.5.2 Market forecast

9 Market disruption with management strategy
9.1 Ultrasound-guided biopsy
9.1.1 Market trends
9.1.2 Market outlook
9.2 Stereotactic-guided biopsy
9.2.1 Market trends
9.2.2 Market forecast
9.3 MRI-guided biopsy
9.3.1 Market trends
9.3.2 Market forecast
9.4 Other
9.4.1 Market trends
9.4.2 Market forecast

10 End-user market disruption
10.1 Hospitals and Clinics
10.1.1 Market trends
10.1.2 Market outlook
10.2 Academic and Research Institutions
10.2.1 Market trends
10.2.2 Market forecast
10.3 Other
10.3.1 Market trends
10.3.2 Market forecast

11 Market breakdown by area
11.1 North America
11.1.1 United States Market trends Market outlook
11.1.2 Canada Market trends Market forecast
11.2 Asia Pacific
11.2.1 China Market trends Market outlook
11.2.2 Japan Market trends Market forecast
11.2.3 India Market trends Market forecast
11.2.4 South Korea Market trends Market forecast
11.2.5 Australia Market trends Market forecast
11.2.6 Indonesia Market trends Market outlook
11.2.7 Other Market trends Market outlook
11.3 Europe
11.3.1 Germany Market trends Market outlook
11.3.2 France Market trends Market forecast
11.3.3 United Kingdom Market trends Market forecast
11.3.4 Italy Market trends Market forecast
11.3.5 Spain Market trends Market forecast
11.3.6 Russia Market trends Market forecast
11.3.7 Other Market trends Market forecast
11.4 Latin America
11.4.1 Brazil Market trends Market outlook
11.4.2 Mexico Market trends Market forecast
11.4.3 Other Market trends Market forecast
11.5 Middle East and Africa
11.5.1 Market trends
11.5.2 Market breakdown by country
11.5.3 Market forecast

12 SWOT review
12.1 Preview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Risks

13 Value chain analysis

14 Five Force Porters Survey
14.1 Preview
14.2 Buyers’ bargaining power
14.3 Bargaining power of suppliers
14.4 Competition Level
14.5 Risk of New Entrants
14.6 Agent Risk

15 Price Indicators

16 Competitive Landscape
16.1 Market Structure
16.2 Key players
16.3 Profiles of key players
16.3.1 Argon Medical Instruments Inc. Company outlook Product Package
16.3.2 B.. Braun Melsungen Company forecast Product Package Finance SWOT Analysis
16.3.3 Becton, Dickinson and Company Company forecast Product Package Finance SWOT Analysis
16.3.4 Boston Scientific Corporation Company forecast Product Package Finance SWOT Analysis
16.3.5 Cardinal Health Inc. Company forecast Product Package Finance SWOT Analysis
16.3.6 Cook Group introduced Company forecast Product Package
16.3.7 Danaher Corporation Company forecast Product Package Finance SWOT Analysis
16.3.8 Hologic, Inc. Company forecast Product Package Finance SWOT Analysis
16.3.9 Medtronic, Inc. Company forecast Product Package SWOT Analysis

For more information on this report, visit

Contact the media:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For EST Office Hours Call + 1-917-300-0470
For US / CAN Toll Free Call + 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Fax USA: 646-607-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Related Links